France: Archimed Diagnostics closes acquisition of ARK Diagnostics
Archimed Diagnostics has closed its carve-out of US-based ARK Diagnostics from listed South Korean specialty chemical company, Soulbrain Holdings. ARK is a global developer...
Switzerland: EQT, ADIA and Auba sell another 8.4% of Galderma
EQT, ADIA and Auba have sold another 8.4% of their holding in Switzerland-based skincare specialist in an overnight share sale, say reports. Bloomberg reports...
Switzerland: Cicor Group strengthens medical technology business with acquisition of two sites from Valtronic
SIX Swiss-listed The Cicor Group, a Switzerland-based, globally active provider of full-cycle electronic solutions from R&D to manufacturing and supply chain management, is strengthening...
UK: Welltower invests £6.4bn in UK senior care homes
New York-listed Welltower, a healthcare infrastructure investor focusing on rental housing for aging seniors across the US, UK, and Canada, has announced US$14bn of acquisitions, primarily comprised of...
UK: GHO Capital announces final close of Fund IV with over €2.5bn of capital
GHO Capital, a European specialist investor in global healthcare, has announces the final close of its fourth fund, GHO Capital IV, raising over €2.5bn...
Switzerland: Novartis to acquire Avidity Biosciences at total equity value of US$12bn
Switzerland-based multi-national pharmaceutical company Novartis has entered into an agreement to acquire Avidity Biosciences, a US-based biopharmaceutical company, for US$72.00 per share (a 46% premium) in...
Germany: FIM Medical becomes leading developer and distributor of European occupational healthcare devices with...
FIM Medical, a prominent player in the French occupational health medical device market, has acquired Vistec, a Germany-based specialist in vision screening devices for the...
Switzerland: EssilorLuxottica accelerates AI driven eye health solutions with acquisition of RetinAI
EssilorLuxottica, a France-based global designer, manufacturer and distributer of advanced vision care products, eyewear and med-tech solutions, has acquired Switzerland-based Ikerian, a health tech...
Australia: ENA Respiratory attracts US$22.4m to fund Phase II development of INNA-051 nasal spray
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of symptomatic viral respiratory infections, has raised US$22.4m in its Series B...
Netherlands: Forbion elevates Mathias Vinther to partner within its Growth Fund
Netherlands-based venture capital investor, Forbion, has promoted Mathias Vinther to partner within its Growth Fund. Vinther joined Forbion in March 2022 as principal, and...
Advertisement
